Form 4: Avid Bioservices CFO Daniel R. Hart Reports Stock Unit Transactions
SEC Form 4 Filing
Daniel R. Hart, CFO of Avid Bioservices, Inc., reports the vesting of performance and restricted stock units.
Summary
- On July 9, 2024, Daniel R. Hart, the Chief Financial Officer of Avid Bioservices, Inc. (CDMO), reported transactions involving performance stock units (PSUs) and restricted stock units (RSUs).
- 136,905 Performance Stock Units vested with a value of $0.00, leaving 265,773 PSUs beneficially owned.
- 68,452 Restricted Stock Units vested with a value of $0.00, leaving 127,375 RSUs beneficially owned.
- The PSUs vest based on Avid Bioservices achieving certain fiscal year revenue and adjusted pre-tax net income milestones over three fiscal years, with 1/3 vesting annually if milestones are met.
- The RSUs vest in sixteen equal quarterly installments over four years, contingent on continuous service.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The vesting of stock units is a standard practice and aligns management with shareholder interests. The vesting is contingent on performance, which is a positive sign.
Positives
- The vesting of stock units aligns executive compensation with company performance, potentially incentivizing value creation.
Risks
- The vesting of PSUs is contingent on achieving specific financial milestones; failure to meet these targets could result in forfeiture of the units.
Future Outlook
The vesting of PSUs is tied to the company's future financial performance over the next three fiscal years.
Industry Context
Stock-based compensation is a common practice in the biopharmaceutical industry to align management incentives with shareholder value.
Comparison to Industry Standards
- Stock unit grants and vesting schedules are common compensation tools in the biotech and CDMO industries.
- Companies like Catalent, Lonza, and Samsung Biologics also utilize similar equity-based compensation plans for their executives.
- The specific vesting terms and performance metrics vary depending on the company's size, growth stage, and strategic priorities.
Stakeholder Impact
- Shareholders: The vesting of PSUs is tied to company performance, potentially benefiting shareholders if milestones are achieved.
- Employees: The vesting of RSUs incentivizes continued service to the company.
Key Dates
| Date | Description |
|---|---|
| 07/09/2024 | Date of transaction (vesting of PSUs and RSUs) |
| 10/09/2024 | Start date for quarterly vesting of RSUs |
| 04/30/2025 | End of first fiscal year for PSU performance period |
| 04/30/2027 | End of final fiscal year for PSU performance period |
| 07/11/2024 | Date of Form 4 signature |
Keywords
Avid Bioservices, CDMO, Daniel R. Hart, CFO, Performance Stock Units, Restricted Stock Units, Vesting, Form 4, SEC
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.